After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NYSE and operates within the Healthcare Plans industry segment. The current market capitalization of Humana Inc is $31.55B. A total of 1.56 million shares were traded on the day, compared to an average of 1.72M shares.
Insider Activity
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, HUM has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, Huval Timothy S. bought 1,247 shares of HUM for 258.58 per share on Feb 24 ’25. In a previous transaction on Dec 31 ’24, Huval Timothy S. sold 3,703 shares at 256.26 per share. HUM shares that Chief Administrative Officer owns now total 8,181.
Among the insiders who bought shares, Huval Timothy S. acquired of 3,703 shares on Dec 31 ’24 at a per-share price of $253.42. In another insider transaction, William K. Fleming bought 8,661 shares at $283.06 per share on Dec 06 ’24.
Dividend
The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Humana Inc pays an annual dividend of $3.54, resulting in a dividend yield of 1.35%, and it has a price to earnings (P/E) ratio of 26.26. HUM’s most recent ex-dividend date was 1.33% when it declared a $0.8850 quarterly dividend that was paid in cash on 3/28/2025. Previously, the company paid the dividend on 12/31/2024 with an ex-dividend date of 1.37%. The HUM stock dividend was $0.8850 per share in cash.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for HUM in the last 3 months, the mean price target is $285.90 with high estimates of $337.00 and low estimates of $241.00. In terms of 52-week highs and lows, HUM has a high of $406.46 and a low of $213.31.
As of this writing, HUM has an earnings estimate of $9.75 per share for the current quarter. EPS was calculated based on a consensus of 21.0 estimates, with a high estimate of $11.18 per share and a lower estimate of $5.74.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. HUM’s latest balance sheet shows that the firm has $16.59B in Cash & Short Term Investments as of fiscal 2021. Its Book Value Per Share was $135.73, while its Total Shareholder’s Equity was $16.10B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HUM is Buy with a score of 3.48.
